Birch Hill Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $66M | Buy |
148,314
+10
| +0% | +$4.45K | 2.93% | 12 |
|
|
2025
Q1 | $71.9M | Sell |
148,304
-24,517
| -14% | -$11.9M | 3.41% | 9 |
|
|
2024
Q4 | $69.6M | Buy |
172,821
+4,664
| +3% | +$1.88M | 3.24% | 10 |
|
|
2024
Q3 | $78.2M | Sell |
168,157
-3,342
| -2% | -$1.55M | 3.67% | 8 |
|
|
2024
Q2 | $80.4M | Sell |
171,499
-231
| -0.1% | -$108K | 3.89% | 7 |
|
|
2024
Q1 | $71.8M | Sell |
171,730
-15,604
| -8% | -$6.52M | 3.49% | 7 |
|
|
2023
Q4 | $76.2M | Buy |
187,334
+1,654
| +0.9% | +$673K | 4.06% | 6 |
|
|
2023
Q3 | $64.6M | Sell |
185,680
-915
| -0.5% | -$318K | 3.85% | 8 |
|
|
2023
Q2 | $65.7M | Sell |
186,595
-4,835
| -3% | -$1.7M | 3.77% | 7 |
|
|
2023
Q1 | $60.3M | Sell |
191,430
-12,893
| -6% | -$4.06M | 3.75% | 5 |
|
|
2022
Q4 | $59M | Sell |
204,323
-6,173
| -3% | -$1.78M | 3.76% | 7 |
|
|
2022
Q3 | $60.9M | Sell |
210,496
-6,750
| -3% | -$1.95M | 4.12% | 5 |
|
|
2022
Q2 | $61.2M | Sell |
217,246
-16,856
| -7% | -$4.75M | 3.82% | 5 |
|
|
2022
Q1 | $61.1M | Sell |
234,102
-13,137
| -5% | -$3.43M | 3.26% | 9 |
|
|
2021
Q4 | $54.3M | Buy |
247,239
+50,095
| +25% | +$11M | 2.69% | 14 |
|
|
2021
Q3 | $35.8M | Buy |
197,144
+1,570
| +0.8% | +$285K | 1.92% | 23 |
|
|
2021
Q2 | $39.4M | Buy |
195,574
+39,389
| +25% | +$7.94M | 2.12% | 20 |
|
|
2021
Q1 | $33.6M | Buy |
+156,185
| New | +$33.6M | 1.91% | 24 |
|